New CEO at Pierre Fabre

Olivier Bohuon will be replacing Jean-Pierre Garnier as chief executive officer (CEO) at Pierre Fabre Group starting Sept. 1, 2010. Until now, Bohuon, 51, was executive vice-president of the Abbott Corporation and president of its pharmaceutical division. As such, he ran the group’s entire pharmaceutical activities from Chicago ($22 billion in sales). In 2003, he was named the group’s president for European operations and later became president of Abbott International.

Prior to that, before beginning his career at Roussel Uclaf in Morocco (and later in the Middle East), Bohuon was the marketing director and then the operations director of Glaxo France (1991-1995), CEO and then president of SmithKline Beecham Laboratories (1995- 2001), and director of GlaxoSmithKline’s Commercial Operations, Europe (2001-2003).

In addition to his duties as the group’s CEO, he will also act as president of Pierre Fabre Medicament. When his arrival at Pierre Fabre was announced, Bohuon stated, “I will head the group in close collaboration with his chairman and founder and we will jointly paving the future; my action will be registered in the long run.”